JPML Refuses To Consolidate Cymbalta Cases

Law360, New York (December 10, 2014, 6:36 PM EST) -- The U.S. Judicial Panel on Multidistrict Litigation on Wednesday rejected a bid by plaintiffs to consolidate more than two dozen suits over Eli Lilly & Co.'s antidepressant Cymbalta, which they claim causes serious health problems the drugmaker misled consumers about.

The JPML rejected the plaintiffs' bid to consolidate the suits in California, finding that centralizing the cases would not be efficient with cases that were in different developmental stages, according to its opinion. Some of the earliest cases in the dispute were filed around mid-2013, and...
To view the full article, register now.



Case Information

Case Title

McDowell v. Eli Lilly and Company

Case Number



New York Southern

Nature of Suit

Personal Inj. Prod. Liability


Robert W. Sweet

Date Filed

June 4, 2013

Law Firms


Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.